secwatch.observer — SEC 8-K summary
======================================

Issuer:     KalVista Pharmaceuticals, Inc. (KALV)
CIK:        0001348911
Form:       8-K
Filed at:   2025-08-21T23:59:59+00:00
Accession:  0001193125-25-185382
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

KalVista sets June 18, 2026 as annual meeting date; stockholder deadlines revised
--------------------------------------------------------------------------------

- 2026 Annual Meeting set for June 18, 2026; changed >30 days from 2025 meeting.
- Stockholder proposals for proxy inclusion due January 6, 2026.
- Other proposals or director nominations due August 31, 2025 (10 days after this 8-K).
- Universal proxy rule compliance required for soliciting proxies in support of non-company nominees.
- Advance notice procedures per Bylaws apply; notice to Cambridge, MA address.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348911/000119312525185382/0001193125-25-185382-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348911/000119312525185382/d928596d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-185382

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer